💨 Abstract

Researchers are set to test a gene-edited pig liver as a temporary solution for people experiencing sudden liver failure, aiming to allow the patient's own liver time to heal. The FDA has approved a clinical trial for this innovative approach, using a device to externally pump a patient's blood through the genetically modified pig liver.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖